Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Krystal Biotech Inc

(NASDAQ: KRYS)
Add to Portfolio
+0.47 (+0.97%)
as of Sep 20, 2019

Last 48.98
Change +0.47 (+0.97%)
Open 48.47
Prev. Close 48.51
Today's Range
47.02
49.42
52wk Range
14.30
51.67
Volume 925,800
Avg Volume 189,395
Sector SIC-2836 Biological Products, (No Disgnostic Substanc

Perfomance Comparison

Name Today 3-Month 1-Year
KRYS +0.97% +8.29% +188.12%
DJIA -0.59% -0.56% +1.04%
S&P 500 -0.49% -0.26% +2.09%

Key Statistics

Annual EPS -1.20
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 812,430
Weighted Alpha +98.40
Standard Deviation +0.21
Profit Margin N/A
Beta 1.07

Growth Rates

YTD +135.71%
1-Year +190.17%

Opinion

Sell Hold Buy

Recent Headlines

Krystal Biotech Announces Initiation of Phase 1/2

GlobeNewswire via COMTEX - Wed Sep 04, 08:00AM EDT
Krystal Biotech Inc., ("Krystal") (NASDAQ: KRYS), a gene therapy company developing medicines to treat rare skin diseases, today announced the initiation of the Phase 1/2 study of KB105 in transglutaminase-1 (TGM1) deficient autos(full story)
KRYS: 48.98 (+0.47)

Krystal Biotech Announces Attendance at Citi's 14th

GlobeNewswire via COMTEX - Tue Aug 27, 04:05PM EDT
Krystal Biotech Inc., ("Krystal") (NASDAQ: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from skin diseases, today announced that Krish S. Krishnan, chairman and (full story)
KRYS: 48.98 (+0.47)

Krystal Biotech Reports Second Quarter 2019 Financial

GlobeNewswire via COMTEX - Mon Aug 05, 08:00AM EDT
FDA grants RMAT designation for KB103 to treat dystrophic epidermolysis bullosa (DEB)(full story)
KRYS: 48.98 (+0.47)

Krystal Biotech, Inc. Added to the Russell 2000 Index

GlobeNewswire via COMTEX - Mon Jul 01, 09:12AM EDT
Krystal Biotech Inc., ("Krystal") (NASDAQ: KRYS), a gene therapy company developing medicines to treat skin diseases, today announces that it has been added to the Russell 2000 Index, effective after the stock market close on June(full story)
KRYS: 48.98 (+0.47)

Krystal Biotech Announces Pricing of $100.0 Million

GlobeNewswire via COMTEX - Mon Jun 24, 07:50PM EDT
Krystal Biotech, Inc. (Nasdaq: KRYS) (the "Company"), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases, today announced that it has priced the (full story)
KRYS: 48.98 (+0.47)